Nv Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 09-12-2024
- Paid Up Capital ₹ 0.50 M
as on 09-12-2024
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 535.18%
(FY 2022)
- Ebitda 104.93%
(FY 2022)
- Net Worth 29.72%
(FY 2022)
- Total Assets 82.44%
(FY 2022)
About Nv Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Nitin Jain and Iuliia Cherkashyna serve as directors at the Company.
- CIN/LLPIN
U74900MH2009PTC326499
- Company No.
326499
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Nv Remedies Private Limited offer?
Nv Remedies Private Limited offers a wide range of products and services, including Copyright & Trademark, Patent Registration Services, Corporate and Soft Skills Training, Corporate Training, Company Law & Labour Law Consultants, Statutory Compliance Services.
Who are the key members and board of directors at Nv Remedies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Iuliia Cherkashyna  | Director | 10-Aug-2018 | Current |
Nitin Jain  | Director | 02-Dec-2019 | Current |
Financial Performance of Nv Remedies.
Nv Remedies Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 535.18% increase in profit. The company's net worth Soared by an impressive increase of 29.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nv Remedies?
In 2019, Nv Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mili Healthcare Private LimitedActive 23 years 1 monthNitin Jain and Iuliia Cherkashyna are mutual person
- Specter Healthcare Intelligence Private LimitedActive 2 years 5 months
Nitin Jain is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nv Remedies?
Unlock and access historical data on people associated with Nv Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nv Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nv Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
